Increased serum glutamate in depressed patients
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Glutamate concentration was determined in serum from endogenous and neurotic depressive patients, in persons with schizophrenia or schizoaffective disorder, and in normal subjects. The mean serum glutamate level in the endogenous and neurotic depressive patients was found to be significantly higher than in any of the other groups. No other statistically significant differences were found. Statistical analysis revealed that the elevated serum glutamate concentration in the endogenous and neurotic depressive patients was probably caused by medication. These results are discussed in view of the effect of antidepressants upon the serum glutamate in the affective disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is supported by findings of elevated serum and plasma glutamate levels in patients85,86 and reduction of plasma glutamate levels following treatment with selective serotonin reuptake inhibitors (SSRIs).87”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [85]
Citations
Cites
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V. (1976) · Science · doi:10.1126/science.1246632 · Cited by 682
5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides
Shaw, D. M., Camps, F. E., & Eccleston, E. G. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.505.1407 · Cited by 431
Graham, L. T., & Aprison, M. H. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90110-2 · Cited by 387
KINETICS OF COMPETITIVE INHIBITION OF NEUTRAL AMINO ACID TRANSPORT ACROSS THE BLOOD‐BRAIN BARRIER
Pardridge, W. M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb07714.x · Cited by 367
VAN PRAAG, H. M., KORF, J., & PUITE, J. (1970) · Nature · doi:10.1038/2251259b0 · Cited by 249
Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients
Mendels, J., Frazer, A., Fitzgerald, R. G., Ramsey, T. A., & Stokes, J. W. (1972) · Science · doi:10.1126/science.175.4028.1380 · Cited by 179
TOTAL AND FREE TRYPTOPHAN CONCENTRATION IN THE PLASMA OF DEPRESSIVE PATIENTS
Coppen, A., Eccleston, E. G., & Peet, M. (1973) · The Lancet · doi:10.1016/s0140-6736(73)93259-5 · Cited by 166
Biochemical post-mortem findings in depressed patients
Birkmayer, W., & Riederer, P. F. (1975) · Journal of Neural Transmission · doi:10.1007/bf01663627 · Cited by 118
Angst, J., Woggon, B., & Schoepf, J. (1977) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00346485 · Cited by 95
Møller, S., Kirk, L., & Honoré, P. (1980) · Journal of Affective Disorders · doi:10.1016/0165-0327(80)90021-x · Cited by 82
Research works printed but not linked: 2
- Munro HN (1979) Factors in the regulation of glutamate metabolism. In: Filer JLJ, Garattini S, Kare MR, Reynolds WA, Wurtman RJ (eds) Adv Biochem Physiol. Raven Press, New York, pp 55?68
- Stegink LD, Reynolds WA, Filer JLJ, Baker GL, Daabees TT, Pitkin RM (1979) Comparative metabolism of glutamate in the mouse, monkey, and man. In: Filer JLJ, Garattini S, Kare MR, Reynolds WA, Wurtman RJ (eds) Adv Biochem Physiol. Raven Press, New York, pp 85?102
Cited by
Items 101–200 of 218
Brown, S. J., Brown, A. M., Purves-Tyson, T. D., Huang, X., Weickert, C. S., & Newell, K. A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.12.039 · Cited by 26
Perisynaptic astrocytes as a potential target for novel antidepressant drugs
Frizzo, M. E., & Ohno, Y. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.11.002 · Cited by 26
Geng, L., Qian, F., Qian, J.-F., & Zhang, Z. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.01.006 · Cited by 25
Hlaváčová, N., Li, Y., Pehrson, A. L., Sánchez, C., Bermúdez, I., Csanova, A., Ježová, D., & Franklin, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.008 · Cited by 25
Stoker, A. D., Rosenfeld, D. M., Buras, M. R., Alvord, J. M., & Gorlin, A. W. (2019) · Journal of Pain Research · doi:10.2147/jpr.s217005 · Cited by 25
Réus, G. Z., Matias, B. I., Maciel, A. L., Abelaira, H. M., Ignácio, Z. M., de Moura, A. B., Matos, D., Danielski, L. G., Petronilho, F. C., Carvalho, A. F., et al. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.04.021 · Cited by 24
de Bie, T. H., Balvers, M. G. J., de Vos, R. C. H., Witkamp, R. F., & Jongsma, M. A. (2022) · Food & Function · doi:10.1039/d2fo01358d · Cited by 22
Clinical overview of NMDA-R antagonists and clinical practice
Davoudian, P. A., & Wilkinson, S. T. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.04.004 · Cited by 21
Astrocyte Ezrin defines resilience to stress-induced depressive behaviours in mice
Lin, S.-S., Zhou, B., Liu, S.-L., Ren, X.-Y., Guo, J., Tong, J.-L., Chen, B., Jiang, R., Semyanov, A. V., Yi, C., et al. (2025) · National Science Review · doi:10.1093/nsr/nwaf480 · Cited by 21
Piroli, G. G., Reznikov, L. R., Grillo, C. A., Hagar, J. M., Fadel, J. R., & Reagan, L. P. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.005 · Cited by 20
Chang, C., Chang, Y., Huang, C., Tsai, S., Hsu, S., Huang, S., Lee, C., Chang, W., Lui, C., & Lien, C.-Y. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0344-4 · Cited by 20
de Bie, T. H., Witkamp, R. F., Jongsma, M. A., & Balvers, M. G. J. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122519 · Cited by 19
Réus, G. Z., Abaleira, H. M., Michels, M., Tomaz, D. B., dos Santos, M. A. B., Carlessi, A. S., Matias, B. I., Leffa, D. D., Damiani, A. P., Gomes, V. D. C., et al. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.12.005 · Cited by 19
Uno, K., Takarada, T., Hinoi, E., & Yoneda, Y. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21095 · Cited by 19
Prikhozhan, A. V., Kovalev, G. I., & Раевский, К. С. (1990) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf00842595 · Cited by 18
Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets
Panek, M., Kawalec, P., Malinowska‐Lipień, I., Brzostek, T., & Pilc, A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1836160 · Cited by 17
Plausible Role of Stem Cell Types for Treating and Understanding the Pathophysiology of Depression
Sachdeva, P., Ji, S., Ghosh, S. M., Ghosh, S., Raghunath, M., Kim, H., Bhaskar, R., Sinha, J., & Han, S.-S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030814 · Cited by 11
Effects of amitriptyline on serum glutamate and free tryptophan in rats
Kim, J. S., Schmid‐Burgk, W., Claus, D., & Kornhuber, H. H. (1982) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00345595 · Cited by 17
Self-citationSerum-based metabolomics characterization of patients with reticular oral lichen planus
Li, X., Zhang, S., & Yang, X.-Y. (2019) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2019.01.019 · Cited by 15
Takahashi, K., Saitoh, A., Yamada, M., Maruyama, Y., Hirose, N., Kamei, J., & Yamada, M. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08149fp · Cited by 15
The possible place for psychedelics in pharmacotherapy of mental disorders
Wojtas, A. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00550-9 · Cited by 14
Decreased Serum Glutamate Levels in Male Adults with Internet Gaming Disorder: A Pilot Study
Paik, S.-H., Choi, M., Kwak, S. M., Bang, S. H., & Kim, D. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.3.276 · Cited by 13
Depressive Disorder Affects TME and Hormonal Changes Promoting Tumour Deterioration Development
Dong, J., Du, J., Liu, R., Gao, X., Wang, Y., Ma, L., Yang, Y., Wu, J. H., Yu, J., & Liu, N. (2025) · Immunology · doi:10.1111/imm.13933 · Cited by 12
Cheng, S., Li, J., Chien, Y.-C., Chang, J. P., Shityakov, S., Huang, S., Gałecki, P., & Su, K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.11.006 · Cited by 12
Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Psychiatry.
Sakamoto, S., Kawai, H., Okahisa, Y., Tsutsui, K., Kanbayashi, T., Tanaka, K., Mizuki, Y., Takaki, M., & Yamada, N. (2019) · PubMed · doi:10.18926/amo/56860 · Cited by 11
Chen, S. X., Lin, Z., Tan, K.-L., Chen, R., Su, W., Zhao, H., Tan, Q., & Tan, W. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.564843 · Cited by 11
Evidence for the contribution of vasopressin V1B receptors in the pathophysiology of depression
Guan, W., Wang, Q., & Sheng, X.-M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116672 · Cited by 10
Kumar, P., Harmer, C. J., & Dourish, C. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00012-3 · Cited by 10
Curing the brain: in search for new astrocyte-specific therapies
Verkhratsky, A., Lee, C. J., Chun, H., Göritz, C., Harkany, T., Lee, J., Lee, S., Lindskog, M., Koh, W., Mulder, J., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01712-4 · Cited by 9
Lages, Y., Balthazar, L., Krahe, T. E., & Landeira-Fernández, J. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221012121534 · Cited by 9
Inflammatory Biomarkers and Depression
Müller, N., Myint, A.-M., & Schwarz, M. (2010) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_7 · Cited by 10
Huang, M., Li, Y., Thomas, A. G., Sharma, A., Liyanage, W., Tichý, T., Tenora, L., Su, Y., Ha, J., Hin, N., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00759 · Cited by 8
Metabotropic glutamate receptor function and regulation of sleep-wake cycles
Holter, K. M., Pierce, B. E., & Gould, R. W. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2022.11.002 · Cited by 8
Wu, Y., Zhang, Q., Qi, Y., Gao, J., Li, W., Lv, L., Chen, G., Zhang, Z., Yue, X., & Peng, S. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14496 · Cited by 8
Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression
Zhao, Y., Wan, J., & Li, Y. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16046 · Cited by 7
The Interacting Neuroendocrine Network in Stress-Inducing Mood Disorders
Leff, P., Hernández, M. E., Becerril‐Villanueva, E., Martinez, C. B. D. R., Téllez-Santillán, C., Pérez-Tapia, M., Salazar, A., Antón, B., Berlanga, C., & Pavón, L. (2010) · The Open Neuroendocrinology Journal · doi:10.2174/1876528901003010180 · Cited by 6
Bear, T. (2023) · Massey Research Online (Massey University) · Cited by 6
Khabazghazvini, B., Groer, M. E., Fuchs, D., Strassle, P. D., Lapidus, M., Sleemi, A., Cabassa, J. B., & Postolache, T. T. (2010) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2010.002 · Cited by 5
Losenkov, I. S., Boiko, A. S., Levchuk, L. A., Simutkin, G. G., Bokhan, N. A., & Ivanova, S. А. (2018) · Neurochemical Journal · doi:10.1134/s1819712418030066 · Cited by 5
Smaga, I., Krzyżanowska, W., Pomierny, B., Maciejska, A., Skórkowska, A., Budziszewska, B., Pilc, A., & Nowak, G. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_176 · Cited by 5
Anti-Inflammatory and Immune-Modulatory Therapeutic Approaches in Major Depression
Müller, N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802456-0.00004-2 · Cited by 4
Hashimoto, K. (2017) · Neuromethods · doi:10.1007/978-1-4939-7228-9_16 · Cited by 4
An Overview of Machine Learning Applications in Mood Disorders
Topolski, N., Jeong, S. H., & Mwangi, B. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.017 · Cited by 4
Antidepressant-Like Effects of Ketamine on Fear Conditioning and Extinction
Kulyk, B. D. (2017) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 4
Mechanisms of Depression in the Epileptic Brain
Jones, N. C., & Maguire, J. L. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0061 · Cited by 3
Clinical Trials of Anti-Inflammatory Treatments of Major Depression
Müller, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00028-3 · Cited by 3
Mood Disorders: Brain Imaging and Therapeutic Implications
(2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018 · Cited by 3
Role of Neurotoxicity in Depression
Smaga, I., Krzyżanowska, W., Pomierny, B., Budziszewska, B., Pilc, A., & Nowak, G. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_176 · Cited by 3
Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder
MacKinnon, D. F. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch50 · Cited by 3
The Role of mTOR in Mood Disorders Pathophysiology and Treatment
Réus, G. Z., Pitcher, M. R., Arent, C. O., & Quevedo, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00015-3 · Cited by 2
Neuroimaging Studies of Effects of Psychotherapy in Depression
Bauer, I. E., & Meyer, T. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.021 · Cited by 2
Dysregulation of the Glutamatergic System in Major Depressive Disorder
Cooper, T. M., & Iosifescu, D. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-58131-8.00012-4 · Cited by 2
Electrophysiological Biomarkers for Mood Disorders
Ramakrishnan, N., Murphy, N., Selvaraj, S., & Cho, R. Y. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.015 · Cited by 2
Ebrahimzadeh, M. A. (2021) · uO Research (University of Ottawa) · doi:10.20381/ruor-25985 · Cited by 2
Visser, G. P. (2012) · Boloka Institutional Repository (North-west University) · Cited by 2
Entzündliche Veränderungen als gemeinsame Pathogenese affektiver und schizophrener Erkrankungen
Müller, N., & Schwarz, M. (2010) · Springer eBooks · doi:10.1007/978-3-211-92215-6_5 · Cited by 1
Association of SLC1A2 and SLC17A7 polymorphisms with major depressive disorder in a Thai population
Thaweethee-Sukjai, B., Suttajit, S., Thanoi, S., Dalton, C., Reynolds, G. P., & Nudmamud‐Thanoi, S. (2018) · Asian Biomedicine · doi:10.1515/abm-2019-0012 · Cited by 1
Brain Imaging and the Mechanisms of Antidepressant Action
Godlewska, B. R., Selvaraj, S., & Cowen, P. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.020 · Cited by 1
Effects of Lithium on Brain Structure in Bipolar Disorder
Kaur, J., Kafantaris, V., & Szeszko, P. R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.018 · Cited by 1
Functional Connectome in Bipolar Disorder
Cha, J., & Anand, A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.008 · Cited by 1
Smaga, I., Krzyżanowska, W., Pomierny, B., Maciejska, A., Skórkowska, A., Budziszewska, B., Pilc, A., & Nowak, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_176-1 · Cited by 1
Inflammatory Biomarkers and Depression
Müller, N., Myint, A.-M., & Schwarz, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7264-3_8 · Cited by 1
Molecular Pathogenesis for Schizophrenia and Major Depression
Müller, N., & Schwarz, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_36 · Cited by 1
Plasticity based strategies for the treatment of depression
Apazoglou, K. (2012) · theses.fr (ABES) · doi:10.70675/1ffaa907z696az4218zacbfzac7807473e37 · Cited by 1
Iskandarani, E. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3466 · Cited by 1
The molecular and behavioral function of SLC6A15, a novel candidate gene for depression
Santarelli, S. (2015) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.19973 · Cited by 1
Zhu, X., Nedelcovych, M. T., Thomas, A. G., Hasegawa, Y., Moreno-Megui, A., Coomer, W., Vohra, V., Saito, A., Perez, G., Wu, Y., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0354-3 · Cited by 1
Calcium signaling cascades, antidepressants and major depressive disorders
Paul, I. A. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8344-3_5
Future perspectives on the pharmacological management of depression
Yates, S., Smith, E., Alhaj, H. A., & McAllister-Williams, H. (2013) · Clinical Investigation · doi:10.4155/cli.12.152
Effetto della memantina su modelli animali di disturbi dell'umore
Demontis, F. (2015) · UnissResearch (Università degli Studi di Sassari)
EFEITO ANTIDEPRESSIVO DA LAMOTRIGINA NO MODELO DE NATAÇÃO FORÇADA MODIFICADO EM RATOS
Consoni, F. T. (2005) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ativação supraespinal da via das quinureninas contribui para a manutenção da dor neuropática
Reis, D. A. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2016.tde-29052015-154850
Oncodynamic Effect of Cancer on Depression
Nashed, M. G., Frey, B. N., Rosebush, P. I., & Singh, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-28558-0_6
5-HT7 Receptor Neuroprotection against Excitotoxicity in the Hippocampus
Vasefi, M. (2014) · UWSpace (University of Waterloo)
General anesthetics effects in behavioral modulation: the particular case of ketamine
Almeida, A. M. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/kxc6-3048
Alexander, L. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.35720
Effekt von partiellem Schlafentzug auf das IL-6-Rezeptorsystem bei Depression
Fliegner, V. (2010) · MACAU: Open Access Repository of Kiel University
The effects of perinatal Fluoxetine treatment on offspring behaviour and neurobiology
Millard, S. J. (2019) · Research Online (University of Wollongong)
Imaging Genetic and Epigenetic Markers in Mood Disorders
Poletti, S., Mazza, E. A., Vai, B., & Benedetti, F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.012
Brain Imaging of Reward Dysfunction in Unipolar and Bipolar Disorders
Kumar, P., Jiang, Y., & Whitton, A. E. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.006
Resting-State Functional Connectivity in Unipolar Depression
Chen, Z., & Gong, Q. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.007
Brain Imaging Methods in Mood Disorders
Selvaraj, S., Brambilla, P., & Soares, J. C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.002
Kious, B. M., & Renshaw, P. F. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.009
Neuroimaging Brain Inflammation in Mood Disorders
Meyer, J. H. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.011
Functional Near-Infrared Spectroscopy Studies in Mood Disorders
Matsuo, K., & Matsubara, T. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.014
Neuroanatomical Findings in Unipolar Depression and the Role of the Hippocampus
Arnone, D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.003
Neuroimaging Biomarkers in Pediatric Mood Disorders
West, M. P., Tang, W. J., & Singh, M. K. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.005
fMRI Neurofeedback as Treatment for Depression
Skottnik, L., & Linden, D. E. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.013
Neuroanatomical Findings in Bipolar Disorder
Tronchin, G., & McDonald, C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.004
Imaging Glutamatergic and GABAergic Abnormalities in Mood Disorders
Scotti-Muzzi, E., Otaduy, M. C. G., Soeiro‐de‐Souza, M. G., & Machado‐Vieira, R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.010
Molecular Imaging of Dopamine and Antipsychotics in Bipolar Disorder
Jauhar, S. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.019
Magnetoencephalography Studies in Mood Disorders
Nugent, A. C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.016
Behavioural and molecular effects induced by Cannabidiol in animal models of depression
Silote, G. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2021.tde-29092021-060118
Diabetes and Depression: A Bidirectional Phenomenon
Modak, S., Ghosh, M., Chakraborty, M., Chutia, D., & Bhuyan, N. R. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v70i02.005
Sebastiano, D., & Andrea, R. C. (2012) · Scholarship@Western (Western University)
Selvaraj, S., Brambilla, P., & Soares, J. C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.022
Selvaraj, S., Brambilla, P., & Soares, J. C. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.001
Tary, E. T., Qujeq, D., Kheirkhah, F., & Hajian‐Tilaki, K. (2024) · International Journal of Medical Laboratory · doi:10.18502/ijml.v11i1.16546
Metadata
- Authors
- Kim, J. S., Schmid-Burgk, W., Claus, D., & Kornhuber, H. H.
- Affiliations
- Universität Ulm (DE)
- Venue
- Archiv f�r Psychiatrie und Nervenkrankheiten
- Published
- 1982-12
- Volume
- 232
- Issue
- 4
- Pages
- 299-304
- ISSN
- 0003-9373 (ISSN-L)
- 1433-8491
- OpenAlex
- W1971437356
- Cited by
- 189
- References
- 16
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 28 · 2020: 11 · 2019: 9 · 2018: 11 · 2017: 13 · 2016: 9 · 2015: 5 · 2014: 11 · 2013: 10 · 2012: 10
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Archives of Psychiatry and Clinical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- serum glutamate, depression, endogenous depression, neurotic depression, schizophrenia, schizoaffective disorder, antidepressants, medication effects, mood disorders, amino acid metabolism
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Depressive Disorder, Female, Glutamates, Humans, Male, Middle Aged, Psychotic Disorders, Schizophrenia, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.